J 2006

Polymorphism of DRD2 gene and ADHD

ŠERÝ, Omar, Ivana DRTÍLKOVÁ, Pavel THEINER, Renáta PITELOVÁ, Radim ŠTAIF et. al.

Základní údaje

Originální název

Polymorphism of DRD2 gene and ADHD

Název česky

Polymorfizmum genu pro DRD2 a ADHD

Název anglicky

Polymorphism of DRD2 gene and ADHD

Autoři

ŠERÝ, Omar (203 Česká republika, garant), Ivana DRTÍLKOVÁ (203 Česká republika), Pavel THEINER (203 Česká republika), Renáta PITELOVÁ (203 Česká republika), Radim ŠTAIF (203 Česká republika), Vladimír ZNOJIL (203 Česká republika) a Jan LOCHMAN (203 Česká republika)

Vydání

Neuroendocrinology Letters, Sweden, Stockholm, Maghira and Maas Publications, 2006, 0172-780X

Další údaje

Jazyk

čeština

Typ výsledku

Článek v odborném periodiku

Obor

30000 3. Medical and Health Sciences

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 0.924

Kód RIV

RIV/00216224:14310/06:00016583

Organizační jednotka

Přírodovědecká fakulta

UT WoS

000238667700040

Klíčová slova anglicky

ADHD; dopamine; DRD2; polymorphism; association; gene

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 13. 2. 2008 17:32, prof. RNDr. Omar Šerý, Ph.D.

Anotace

V originále

Objectives: Attention deficit hyperactivity disorder (ADHD) is a prevalent childhood disorder. Evidence from the family and twin studies suggest that ADHD is familiar and highly heritable. Association studies are frequently used for the searching of markers responsible for genetic basis of ADHD. We investigated TaqI polymorphism of the dopamine receptor D2 (DRD2) in relationship with ADHD. The association between TaqI A polymorphism of DRD2 gene and ADHD has previously been published. Design: We used the association study to test the relationship between TaqI A polymorphism of DRD2 gene and ADHD on groups of ADHD boys and control boys. Setting: For DNA isolation, buccal tissue was used. PCR with restriction analysis of PCR products was used for genotyping. Results: We found statistically different genotypic and allelic frequencies (p < 0,008, p < 0,002, respectively) of DRD2 polymorphism between two studied groups of boys. Main findings: According to our results we suppose that polymorphism TaqI A of DRD2 gene is involved in the pathogenesis of childhood ADHD in male subjects. Allele A1 and genotype A1A1 in male subjects is associated with ADHD. Conclusions: Our study confirmed the relationship between TaqI A polymorphism of DRD2 gene and ADHD published previously.

Anglicky

Objectives: Attention deficit hyperactivity disorder (ADHD) is a prevalent childhood disorder. Evidence from the family and twin studies suggest that ADHD is familiar and highly heritable. Association studies are frequently used for the searching of markers responsible for genetic basis of ADHD. We investigated TaqI polymorphism of the dopamine receptor D2 (DRD2) in relationship with ADHD. The association between TaqI A polymorphism of DRD2 gene and ADHD has previously been published. Design: We used the association study to test the relationship between TaqI A polymorphism of DRD2 gene and ADHD on groups of ADHD boys and control boys. Setting: For DNA isolation, buccal tissue was used. PCR with restriction analysis of PCR products was used for genotyping. Results: We found statistically different genotypic and allelic frequencies (p < 0,008, p < 0,002, respectively) of DRD2 polymorphism between two studied groups of boys. Main findings: According to our results we suppose that polymorphism TaqI A of DRD2 gene is involved in the pathogenesis of childhood ADHD in male subjects. Allele A1 and genotype A1A1 in male subjects is associated with ADHD. Conclusions: Our study confirmed the relationship between TaqI A polymorphism of DRD2 gene and ADHD published previously.

Návaznosti

MSM0021622413, záměr
Název: Proteiny v metabolismu a při interakci organismů s prostředím
Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Proteiny v metabolismu a při interakci organismů s prostředím
NF6520, projekt VaV
Název: Klinické a molekulárně-biologické koreláty hyperkinetické poruchy v dětském věku
Investor: Ministerstvo zdravotnictví ČR, Klinické a molekulárně-biologické koreláty hyperkinetické poruchy v dětském věku